Nyxoah secures €375 million for sleep apnea treatment
TLDR: Belgian medtech Nyxoah secures €37.5 million EIB venture-debt financing to treat obstructive sleep apnea. The European Investment Bank (EIB) is providing venture debt financing to Nyxoah to develop innovative solutions for